Report overview
Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
This report aims to provide a comprehensive presentation of the global market for Nitroglycerin for Angina, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitroglycerin for Angina. This report contains market size and forecasts of Nitroglycerin for Angina in global, including the following market information:
Global Nitroglycerin for Angina Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Nitroglycerin for Angina Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Nitroglycerin for Angina companies in 2022 (%)
The global Nitroglycerin for Angina market was valued at US$ 25 million in 2022 and is projected to reach US$ 32 million by 2029, at a CAGR of 3.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nitroglycerin for Angina include Pfizer, Espero Pharmaceuticals, Us Pharma, Mylan, Sandoz, Hercon Pharmaceuticals, Glenmark, Sigmapharm Laboratories and Dr. Reddy's Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nitroglycerin for Angina manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nitroglycerin for Angina Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Nitroglycerin for Angina Market Segment Percentages, by Type, 2022 (%)
Tablet
Powder
Transdermal
Global Nitroglycerin for Angina Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Nitroglycerin for Angina Market Segment Percentages, by Application, 2022 (%)
Relief
Prophylaxis
Global Nitroglycerin for Angina Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Nitroglycerin for Angina Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nitroglycerin for Angina revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nitroglycerin for Angina revenues share in global market, 2022 (%)
Key companies Nitroglycerin for Angina sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nitroglycerin for Angina sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Espero Pharmaceuticals
Us Pharma
Mylan
Sandoz
Hercon Pharmaceuticals
Glenmark
Sigmapharm Laboratories
Dr. Reddy's Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nitroglycerin for Angina, market overview.
Chapter 2: Global Nitroglycerin for Angina market size in revenue and volume.
Chapter 3: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nitroglycerin for Angina in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nitroglycerin for Angina capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
